当前位置:首页 - 行情中心 - 京新药业(002020) - 财务分析 - 现金流量表

京新药业

(002020)

  

流通市值:85.79亿  总市值:102.03亿
流通股本:7.24亿   总股本:8.61亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金3,011,600,007.981,964,840,434.98949,825,279.233,786,397,989.29
  收到的税费返还39,028,854.1923,427,975.1611,189,012.8246,620,740.78
  收到其他与经营活动有关的现金66,399,250.6546,168,125.7321,780,413.13113,274,579.7
  经营活动现金流入小计3,117,028,112.822,034,436,535.87982,794,705.183,946,293,309.77
  购买商品、接受劳务支付的现金926,996,926.23593,599,784.54319,050,733.691,432,363,922.98
  支付给职工以及为职工支付的现金497,717,599.42350,805,223.67167,685,869.19628,410,872.32
  支付的各项税费334,393,204.98252,386,224.68148,980,607.24353,287,492.08
  支付其他与经营活动有关的现金590,433,123.94360,733,261.79165,221,029.09750,883,949.55
  经营活动现金流出小计2,349,540,854.571,557,524,494.68800,938,239.213,164,946,236.93
  经营活动产生的现金流量净额767,487,258.25476,912,041.19181,856,465.97781,347,072.84
二、投资活动产生的现金流量:
  收回投资收到的现金3,733,318,253.382,616,318,253.381,634,260,381.922,709,900,100
  取得投资收益收到的现金70,920,117.9539,432,702.1125,639,901.0927,159,592.45
  处置固定资产、无形资产和其他长期资产收回的现金净额929,871644,259256,2333,887,457.6
  投资活动现金流入小计3,805,168,242.332,656,395,214.491,660,156,516.012,740,947,150.05
  购建固定资产、无形资产和其他长期资产支付的现金151,521,350.72126,741,359.7488,213,905.44202,850,821.93
  投资支付的现金4,184,448,635.612,680,632,669.281,867,633,569.282,170,990,352
  投资活动现金流出小计4,335,969,986.332,807,374,029.021,955,847,474.722,373,841,173.93
  投资活动产生的现金流量净额-530,801,744-150,978,814.53-295,690,958.71367,105,976.12
三、筹资活动产生的现金流量:
  取得借款收到的现金274,966,036.39169,250,074.99-566,978,516.64
  收到其他与筹资活动有关的现金89,193,943.4389,193,943.4389,042,500368,162.81
  筹资活动现金流入小计364,159,979.82258,444,018.4289,042,500567,346,679.45
  偿还债务支付的现金355,000,000285,000,00070,000,000567,000,000
  分配股利、利润或偿付利息支付的现金288,437,086.99290,930,276.99-288,540,870.41
  其中:子公司支付给少数股东的股利、利润3,621,841.243,621,841.24-3,687,124.66
  支付其他与筹资活动有关的现金126,067,906.3727,331,413.316,744,654.88627,554,733.13
  筹资活动现金流出小计769,504,993.36603,261,690.2986,744,654.881,483,095,603.54
  筹资活动产生的现金流量净额-405,345,013.54-344,817,671.872,297,845.12-915,748,924.09
四、汇率变动对现金及现金等价物的影响-20,882,722.73-16,558,377.64-10,431,386.1-7,217,125.84
五、现金及现金等价物净增加额-189,542,222.02-35,442,822.85-121,968,033.72225,486,999.03
  加:期初现金及现金等价物余额512,631,931.73512,631,931.73512,675,332.7287,144,932.7
  期末现金及现金等价物余额323,089,709.71477,189,108.88390,707,298.98512,631,931.73
补充资料:
  净利润-355,950,434.85-766,667,967.92
  资产减值准备-45,333,057.39-53,295,486.44
  固定资产和投资性房地产折旧-126,068,611.46-252,057,462.72
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-126,068,611.46-252,057,462.72
  无形资产摊销-11,231,284.8-21,257,731.27
  长期待摊费用摊销-7,142,895.89-15,380,447.38
  处置固定资产、无形资产和其他长期资产的损失--6,123,990.05-574,497.63
  固定资产报废损失-5,067,275.98-50,777.86
  公允价值变动损失-16,701,364.37--9,470,848.64
  财务费用-7,737,092.76--33,345,222.17
  投资损失--12,784,347.93--17,108,923.46
  递延所得税--2,480,549.69-8,951,161.55
  其中:递延所得税资产减少-3,634,596.43-4,326,434.38
    递延所得税负债增加--6,115,146.12-4,624,727.17
  存货的减少--55,350,266.7--5,227,251.15
  经营性应收项目的减少-99,757,787.45--26,571,327.94
  经营性应付项目的增加--128,356,975.84--258,731,692.52
  其他----437,868.71
  现金的期末余额-477,189,108.88-512,631,931.73
  减:现金的期初余额-512,631,931.73-287,144,932.7
  现金及现金等价物的净增加额--35,442,822.85-225,486,999.03
公告日期2026-10-292026-08-272026-04-242026-04-24
审计意见(境内)标准无保留意见
TOP↑